0.84 (s, 9 H), 0.049, 0.031, 0.0 (s, 6H); 13C NMR δ 162.3 (C),
151.4 (CH), 139.6, 135.5, 135.3, 131.7, 114.9, 114.4 (C), 87.6, 87.1,
86.4, 85.9, 83.1, 82.8 (CH), 68.3, 68.0 (CH2), 66.9, 66.4 (CH), 63.0,
62.3(CH2), 61.7, 61.5 (CH), 54.3 (CH3), 30.0, 29.7 (CH2), 28.0,
26.2, 25.2 (CH3), 25.0 (CH2), 22.8, 22.6 (CH3), 18.6 (C), -4.9
(CH3); HRMS m/z (M+ + 1) calcd for C25H42N5O5Si 520.2955,
found 520.2943.
derived by reaction of alkyne 8 with nitrone 17 with zinc
in acetic acid was capricious and was generally ac-
companied by significant reduction of the acetylene
moiety to an alkene. Consequently this procedure was
inappropriate for the synthesis of 10.
When the aryllithium 2 was allowed to react with
nitrone 17 at -70 °C the highly basic aryllithium
appeared to promote degradation of the nitrone. Treat-
ment of the crude product with zinc in acetic acid
generated some 4, but in a poor yield relative to that
obtained on treatment of imine 3 with the lithiated 2.
The addition of SnCl4 to the reaction did not improve
matters in this case.
In conclusion, we have shown that SnCl4 promotes the
addition of some aryllithiums to imine 3 and allows the
formation of adduct 13 for the first time. Its use led to
the consistent production of 15 in an enhanced yield.
Importantly, for our purposes, the use of the nitrone 17
has enabled the reproducible synthesis of adduct 18, and
thus the immucillins 11 and 12, on a large scale.
Variations in the efficiencies of the reactions attempted
with compound 17, however, show that each target
compound should be made by the procedure best suited
to the specific purpose.
6-O-Ben zyl-7-N-ben zyloxym eth yl-9-br om o-9-deaza-2-N,N-
bis(4-m eth oxyben zyl)gu a n in e (6a ). Sodium hydride (0.3 g,
60%, 7.5 mmol) was added to a stirred solution of 6-O-benzyl-
7-N-benzyloxymethyl-9-bromo-9-deazaguanine1 (1.2 g, 2.73 mmol)
in DMF (25 mL) followed by 4-methoxybenzyl chloride (1.1 mL,
8.1 mmol). The mixture was stirred for 16 h, toluene (100 mL)
was added, and the solution was washed with water (2×) and
processed in the normal manner. Chromatography of the crude
material afforded the title compound (1.7 g, 2.5 mmol, 91%) as
a white solid. Recrystallized from ethanol it had: mp 102-104
1
°C; H NMR δ 7.31-7.16 (m, 15 H), 6.82 (d, J ) 8.6 Hz, 4 H),
5.56 (s, 2 H), 5.42 (s, 2 H), 4.82 (s, 4 H), 4.39 (s, 2 H), 3.78 (s, 6
H); 13C NMR δ 159.0, 158.5, 156.5, 151.5, 137.4, 137.0 (C), 131.8
(CH), 131.6 (C), 129.7, 128.9, 128.8, 128.4, 128.3, 128.0, 114.3
(CH), 110.5, 91.1(C), 77.9, 70.6, 68.0 (CH2), 55.7 (CH3), 49.4
(CH2). Anal. Calcd for C37H35BrN4O4: C, 65.39; H, 5.19; Br,
11.76; N, 8.24. Found: C, 65.47; H, 5.17; Br, 11.55; N, 8.42.
1-â-(6-O-Ben zyl-7-N-ben zyloxym eth yl-9-d ea za -2-N,N-bis-
(4-m et h oxyb en zyl)gu a n in -9-yl)-5-O-ter t-b u t yld im et h ylsi-
lyl-1,4-dideoxy-1,4-im in o-2,3-O-isopr opylidin e-D-r ibitol (14).
n-Butyllithium (0.33 mL, 1.5 M, 0.5 mmol) was added to a stirred
solution of 6-O-benzyl-7-N-benzyloxymethyl-9-bromo-9-deaza-2-
N,N-bis(4-methoxybenzyl)guanine (0.312 g, 0.46 mmol) in ether
(6 mL) and anisole (3 mL) at -78 °C to give the lithiated 6, and
after 20 min, a solution of imine 3 (0.1 g, 0.35 mmol) was added
followed by SnCl4 (82 µL, 0.7 mmol). Stirring was maintained
for 2 h, after which time NaOH (5 mL, 4 M) and ether (10 mL)
were added. Normal processing and chromatography afforded
the title compound 14 (0.047 g, 0.053 mmol, 15%) as a syrup:
1H NMR δ 0.00 (2s, 6 H), 0.84 (s, 9 H), 1.22 (s, 3 H), 1.53 (s, 3
H), 3.21 (dd, J ) 5.0, 10.1 Hz, 1 H), 3.78 (m, 2 H), 3.80 (s, 9 H),
4.26 (d, J ) 4.80 Hz, 1 H), 4.40 (s, 2 H), 4.44 (m, 1 H), 4.57 (d,
J ) 26.3 Hz, 1 H), 5.02 (m, 2 H), 5.42 (s, 2 H), 5.60 (s, 2 H), 6.81
(s, 1 H), 6.83 (m, 4 H), 7.15-7.30 (m, 9 H); 13C NMR δ 158.9,
157.6, 156.3, 152.5, 137.8, 137.3, 132.0, 130.9, 129.2, 128.8, 128.7,
128.3, 128.1, 127.9, 114.8, 114.1, 111.2, 86.4, 82.4, 77.6, 70.4,
67.5, 66.5, 63.9, 61.5, 55.6, 49.5, 27.9, 26.3, 25.6, 18.8; HRMS
m/z (M+ + 1) calcd for C51H64N5O7Si 886.4575, found 886.4589.
5-O-ter t-Bu t yld im et h ylsilyl-1,4-d id eoxy-1-â-(3,3-d iet h -
oxyp r op -1-yn yl)-1,4-im in o-2,3-O-isop r op ylid en e-N-(2,2,2-
tr ich lor oeth oxycar bon yl)-D-r ibitol (15). n-Butyllithium (109.5
mL, 1.6 M, 175 mmol) was added to a solution of propiolaldehyde
diethyl acetal (27.2 mL, 189.5 mmol) in THF (400 mL) with the
reaction temperature kept below -60 °C, and the solution was
stirred at -70 °C for 20 min. A solution of the imine 3 (20 g,
70.2 mmol) in THF (40 mL) was added followed by stannic
chloride (8.2 mL, 70.2 mmol), and the resulting solution was
stirred at -70 °C for 30 min. Aqueous sodium hydroxide (150
mL, 2.5 M) and petroleum ether (400 mL) were added, and the
organic phase was processed normally to give a syrup (35.4 g).
A solution of this material in dichloromethane (150 mL) was
treated with N,N-diisopropylethylamine (30 mL, 310 mmol) and
then trichloroethyl chloroformate (9.7 mL, 70.4 mmol) with
cooling to control the initial exotherm. After 1 h at 20 °C, the
solution was processed normally and chromatography afforded
title compound 15 as a syrup (31.5 g, 53.5 mmol, 76%) with 1H
and 13C NMR spectra identical to those reported.8
Exp er im en ta l Section
Gen er a l Meth od s. 1H and 13C NMR spectra were recorded
at 300 and 75 MHz, respectively, in CDCl3 unless stated
otherwise. “Normal processing” means the organic phase was
washed with aqueous acid and/or base as appropriate, dried, and
concentrated to dryness. Chromatography was conducted on
silica gel.
Gen er a l P r oced u r e for th e Lew is Acid P r om oted Con -
d en sa tion of Ar yllith iu m 2 w ith Im in e 3. n-Butyllithium
(0.77 mL, 1.5 M, 1.15 mmol) was added to a solution of 7-N-
benzyloxymethyl-9-bromo-9-deaza-6-O-methylhypoxanthine1 (375
mg, 1.08 mmol) in ether (6 mL) and anisole (3 mL) at -45 °C,
and after 10 min, the reaction mixture was cooled to -78 °C. A
solution of the imine 31 (0.1 g, 0.35 mmol) in ether (2 mL) was
added, followed by the Lewis acid (0.7 mmol), and the temper-
ature was kept at -78 °C for 2 h. The reaction was quenched
by the addition of Na2CO3 (saturated, aqueous) or NaOH and
processed in the normal manner. Chromatography afforded
syrupy 4, in those cases in which product was formed, with 1H
and 13C NMR data identical to those reported for the compound.1
5-O-ter t-Bu tyld im eth ylsilyl-1,4-d id eoxy-1,4-im in o-2,3-O-
isop r op ylid en e-1-â-(7-m eth oxy-2-tetr a h yd r op yr a n -2-yl-1H-
p yr a zolo[4,3-d ]p yr im id in -3-yl)-D-r ibitol (13). A stirred so-
lution of 3-bromo-7-methoxy-2-(tetrahydropyran-2-yl)-pyrazolo[4,3-
d]pyrimidine10 (1.0 g, 3.19 mmol) in dry THF at -78 °C was
treated with n-butyllithium (2.2 mL, 1.5 M, 3.3 mmol) to give
the lithiate 5, and after 20 min a solution of the imine 3 (0.63 g,
2.21 mmol) in THF (1 mL) was added followed by SnCl4 (0.51
mL, 4.4 mmol). The mixture was stirred at -70 °C for 2 h and
then allowed to warm to 20 °C over 1 h, after which time the
reaction was quenched by addition of NaOH (10 mL, 4 M). Ether
(20 mL) was added, the organic phase was separated and dried,
and the solvent was evaporated. Chromatography afforded the
title compound 13 (0.355 g, 0.68 mmol, 31%) as a clear oil: 1H
NMR (the product was a ∼ 6:4 diastereomeric mixture due to
the tetrahydropyranyl protecting group) δ 8.38 (s, 1 H), 5.97 (dd,
J ) 9.2, 2.7 Hz, 0.4 H), 5.87 (dd, J ) 9.9, 2.2 Hz, 0.6 H), 5.31
(dd, J ) 6.8, 4.9, Hz 0.6 H), 4.99 (t, J ) 6.4 Hz, 0.4 H), 4.82-
4.69 (m, 2H), 4.15 (s, 3 H), 4.01 (m, 1H), 3.92-3.52 (m, 4H), 3.33
(q, J ) 4.1 Hz, 0.4 H), 3.27 (q, J ) 3.9 Hz, 0.6 H), 2.59 (m, 1 H),
2.08 (m, 2 H), 1.70 (m, 2 H), 1.59, 1.56, 1.34, 1.32 (s, 3 H), 0.88,
5-O-ter t-Bu t yld im et h ylsilyl-1,N-d eh yd r o-1,4-d id eoxy-
1,4-im in o-2,3-O-isop r op ylid en e-D-r ibitol N-Oxid e (17). A
stirred solution of 168 (30 g, 104 mmol) and selenium dioxide
(0.6 g, 5.4 mmol) in acetone (100 mL) was cooled to 0 °C, and
hydrogen peroxide (30%) was added slowly, with the tempera-
ture kept below 4 °C, until the reaction was complete (TLC
evidence) (3-4 h). Chloroform (250 mL) was added, the mixture
was washed with water, and the organic phase was dried
(MgSO4) and concentrated. Chromatography of the crude product
afforded crystalline nitrone 17 (18.3 g, 60.8 mmol, 58%): mp
(10) Stone, T. E.; Eustace, E. J .; Pickering, M. V.; Doyle Daves, G.,
J r. J . Org. Chem. 1979, 44, 505-509.
J . Org. Chem, Vol. 69, No. 6, 2004 2219